Hjem › Skjoldbruskkirtelkræft › Texas › Houston
Skjoldbruskkirtelkræft kliniske forsøg i Houston, TX
12 studier for Skjoldbruskkirtelkræft søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- UT MD Anderson Cancer Center, Houston
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
RekruttererObservationsstudie
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
Rekrutterer
- The University of Texas M. D. Anderson Cancer Center, Houston
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
RekruttererFase 2
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
RekruttererFase 1Frivillige med god helbredstilstand velkomne
- M D Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Rekrutterer
- M D Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Skjoldbruskkirtelkræft forsøg i andre byer
- Washington, DC10 studier
- New York City, NY9 studier
- Boston, MA6 studier
- Philadelphia, PA6 studier
- Nashville, TN5 studier
- Durham, NC5 studier
- Los Angeles, CA5 studier
- San Francisco, CA4 studier
- San Antonio, TX4 studier
- Minneapolis, MN4 studier
- St. Louis, MO4 studier
- Memphis, TN4 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.